Rituximab (R) added to CHOP improves outcome in BCL-6 negative but not in BCL-6 positive DLBCL patients > 60 yearsJ Winter,E Weller, S Horning,M Krajewska,D Variakojis, T Habermann,R Fisher, P Kurtin,W Macon, M Chhanabhai, R Felgar,E Hsi,L Medeiros,J Weick, J Reed,R GascoyneANNALS OF ONCOLOGY（2005）引用 0|浏览11暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
